These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9795451)

  • 1. In vitro activity of newer quinolones on Streptococcus pneumoniae isolated from outpatients.
    Lontie M; Liekens K; Deschilder I
    Acta Clin Belg; 1998 Aug; 53(4):285-6. PubMed ID: 9795451
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of new 4-quinolones in combination with erythromycin or tetracycline against S. pneumoniae.
    Morrissey I; Smith JT
    Drugs; 1995; 49 Suppl 2():226-7. PubMed ID: 8549311
    [No Abstract]   [Full Text] [Related]  

  • 3. Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829.
    Spangler SK; Jacobs MR; Pankuch GA; Appelbaum PC
    J Antimicrob Chemother; 1993 Feb; 31(2):273-80. PubMed ID: 8463172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of fluoroquinolones (gatifloxacin, levofloxacin and trovafloxacin) and seven other antibiotics against Streptococcus pneumoniae.
    Nicodemo AC; Mendes CM; Oplustil CP; Sinto S
    Braz J Infect Dis; 2001 Apr; 5(2):50-2. PubMed ID: 11493408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Kosowska-Shick K; Credito K; Pankuch GA; Lin G; Bozdogan B; McGhee P; Dewasse B; Choi DR; Ryu JM; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin.
    Giron KP; Gross ME; Musher DM; Williams TW; Tharappel RA
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2798-800. PubMed ID: 8593023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation with penicillin resistance.
    Thornsberry C; Ogilvie PT; Holley HP; Sahm DF
    Clin Ther; 1998; 20(6):1179-90. PubMed ID: 9916611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
    Ishigo S; Tamaya T; Matsubara S; Suematsu H; Sawamura H; Matsukawa Y; Hashido H; Iwata I; Mikamo H
    Jpn J Antibiot; 2000 Dec; 53(12):652-9. PubMed ID: 11234221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the degree of penicillin susceptibility of Streptococcus pneumoniae affect the bactericidal activity of co-amoxiclav versus oral cephalosporins at physiological concentrations? An in vitro pharmacodynamic simulation.
    Prieto J; Giménez MJ; Balcabao IP; Gómez-Lus ML; Aguilar L
    J Chemother; 1999 Oct; 11(5):345-8. PubMed ID: 10632379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
    Hoellman DB; Lin G; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1999 May; 43(5):645-9. PubMed ID: 10382885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1995 Jan; 35(1):230-2. PubMed ID: 7768776
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin.
    Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 1997 Nov; 29(3):199-201. PubMed ID: 9401813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activity of trovafloxacin and ceftriaxone or vancomycin against Streptococcus pneumoniae with various penicillin susceptibilities.
    Nicolau DP; Tessier PR; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1998 Apr; 42(4):991-2. PubMed ID: 9559832
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia.
    Urbásková P; Trupl J; Hupková H; Appelbaum PC; Jacobs MR
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):686-8. PubMed ID: 8894582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.
    Prenna M; Montanari MP; Mingoia M; Biavasco F; Ripa S; Varaldo PE
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):816-9. PubMed ID: 9923533
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae.
    Esposito S; Noviello S; Ianniello F
    Chemotherapy; 2001; 47(2):90-6. PubMed ID: 11173809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro bactericidal activities of ABT-773 against ermB strains of Streptococcus pneumoniae.
    Neuhauser MM; Prause JL; Danziger LH; Pendland SL
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1132-4. PubMed ID: 12604554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
    Li J; Zhang Y; Chen Y; Hao F; Chen Y
    Chin Med J (Engl); 2000 Jul; 113(7):628-31. PubMed ID: 11776034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of oral agents against pediatric isolates of Streptococcus pneumoniae.
    Black J; Moland ES; Chartrand SA; Thomson KS
    Diagn Microbiol Infect Dis; 2001 Mar; 39(3):195-7. PubMed ID: 11337189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and penicillin-resistant pneumococci by time-kill methodology.
    Visalli MA; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1996 Jan; 37(1):77-84. PubMed ID: 8647777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.